(1)What (a) number of African, indigenous and/or traditional medicines has each of the entities reporting to him develop to the point where it has undergone clinical testing, been shown scientifically to have beneficial effects and put into production, sale and prescription by qualified medical and traditional professionals (i) in each of the past five financial years and (ii) since 1 April 2020, (b)(i) is the name of each of these medicines and (ii) diseases does each of the specified medicines treat and (c)(i) number of these medicines are currently under investigation, (ii) are the details of the reasons why each is under investigation and (iii) is the current status of each investigation;
(2) what were the details of the cost to develop each of these medicines according to each stage of development as at the latest specified date?